Claus Oxvig Selected Research

Pregnancy-Associated Plasma Protein-A (PAPP-A)

1/2022	Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy.
1/2022	Pregnancy-associated plasma protein-A (PAPP-A) is a key component of an interactive cellular mechanism promoting pulmonary fibrosis.
1/2020	Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer.
1/2020	Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.
11/2019	PAPP-A and the IGF system in atherosclerosis: what's up, what's down?
1/2019	Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion.
1/2018	Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction.
1/2018	PAPP-A and cancer.
1/2018	Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study.
1/2017	Insulin-Like Growth Factor Bioactivity, Stanniocalcin-2, Pregnancy-Associated Plasma Protein-A, and IGF-Binding Protein-4 in Pleural Fluid and Serum From Patients With Pulmonary Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claus Oxvig Research Topics

Disease

12	Neoplasms (Cancer) 02/2022 - 07/2004
7	Atherosclerosis 11/2019 - 02/2007
5	Atherosclerotic Plaque (Atheroma) 05/2016 - 01/2006
4	ST Elevation Myocardial Infarction 01/2018 - 01/2009
4	Acute Coronary Syndrome 12/2015 - 07/2006
3	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2014
3	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 02/2016
3	Myocardial Infarction 01/2009 - 04/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2006 - 04/2004
3	Stable Angina 07/2006 - 04/2004
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2017 - 06/2006
2	Hypertension (High Blood Pressure) 01/2016 - 10/2005
2	Ascites 10/2015 - 04/2015
2	Ovarian Neoplasms (Ovarian Cancer) 04/2015 - 07/2004
2	Dystonia 12 12/2013 - 03/2013
2	Pre-Eclampsia (Preeclampsia) 09/2010 - 01/2009
1	Fibrosis (Cirrhosis) 01/2022
1	Hypertrophy 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020
1	Cysts 01/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2020
1	Short Qt Syndrome 11/2017
1	Cardiac Arrhythmias (Arrythmia) 11/2017
1	Type 2 Diabetes Mellitus (MODY) 05/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Growth Disorders 01/2017
1	Vascular Diseases (Vascular Disease) 05/2016
1	Hypercholesterolemia 02/2016
1	Carcinogenesis 01/2016
1	Microcephaly 01/2016
1	Proteinuria 01/2016
1	Ischemia 12/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2015
1	Carcinoma (Carcinomatosis) 10/2015
1	Dwarfism 02/2015
1	Polymorphic catecholergic ventricular tachycardia 02/2015
1	Decompression Sickness (Bends) 12/2014
1	familial type 2 Hemiplegic migraine 12/2013
1	Nervous System Diseases (Neurological Disorders) 12/2013
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2013
1	Spasm (Spasms) 03/2013
1	Movement Disorders (Movement Disorder) 03/2013
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 09/2010
1	Stillbirth 09/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2010
1	Non-ST Elevated Myocardial Infarction 01/2009

Drug/Important Bio-Agent (IBA)

33	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2022 - 04/2004
10	Insulin-Like Growth Factor I (IGF-1)IBA 02/2022 - 06/2005
7	Insulin-Like PeptidesIBA 01/2018 - 06/2005
6	Insulin-Like Growth Factor Binding ProteinsIBA 01/2020 - 10/2006
6	Insulin-Like Growth Factor Binding Protein 4IBA 01/2018 - 01/2013
5	Metalloproteases (Metalloproteinases)IBA 01/2022 - 02/2007
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2022 - 07/2004
3	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018 - 10/2015
3	Heparin (Liquaemin)FDA LinkGeneric 12/2015 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 06/2006
2	Monoclonal AntibodiesIBA 01/2020 - 02/2016
2	Biological ProductsIBA 01/2017 - 02/2015
2	ApolipoproteinsIBA 05/2016 - 08/2010
2	Blood Proteins (Serum Proteins)IBA 01/2016 - 07/2006
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2016 - 10/2006
2	Adenosine Triphosphatases (ATPase)IBA 12/2013 - 03/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	YF 476IBA 01/2020
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	teleocalcinIBA 01/2018
1	proinsulin-like growth factor IIIBA 01/2018
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2018
1	Chloride-Bicarbonate AntiportersIBA 11/2017
1	AnionsIBA 11/2017
1	Proteoglycans (Proteoglycan)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	GlycosaminoglycansIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 02/2016
1	AcidsIBA 01/2016
1	CollagenIBA 01/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2016
1	4-azidobenzylcarazolol (pABC)IBA 01/2016
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2015
1	Neutralizing AntibodiesIBA 04/2015
1	PlatinumIBA 04/2015
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 02/2015
1	ParaffinIBA 12/2014
1	Formaldehyde (Formol)FDA Link 12/2014
1	Estrogen ReceptorsIBA 12/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2014
1	Phenobarbital (Luminal)FDA Link 12/2014
1	Protein Isoforms (Isoforms)IBA 12/2013
1	Streptozocin (Streptozotocin)FDA Link 10/2013
1	Apolipoproteins E (ApoE)IBA 08/2010

Therapy/Procedure

4	Therapeutics 11/2019 - 10/2006
3	Percutaneous Coronary Intervention 03/2017 - 01/2009
1	Lasers (Laser) 02/2022
1	Ligation 12/2015
1	Drug Therapy (Chemotherapy) 04/2015